TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $158,874 | -9.0% | 11,438 | -6.5% | 0.00% | 0.0% |
| Q4 2023 | $174,599 | -16.8% | 12,235 | -9.8% | 0.00% | -20.0% |
| Q3 2023 | $209,783 | -7.0% | 13,561 | -5.5% | 0.01% | +25.0% |
| Q2 2023 | $225,507 | -12.6% | 14,354 | -8.3% | 0.00% | 0.0% |
| Q1 2023 | $258,033 | +18.7% | 15,657 | +12.3% | 0.00% | +33.3% |
| Q4 2022 | $217,463 | +44.0% | 13,940 | +20.1% | 0.00% | +50.0% |
| Q3 2022 | $151,000 | -83.2% | 11,605 | -78.9% | 0.00% | -83.3% |
| Q3 2021 | $900,000 | +30.8% | 54,985 | +34.6% | 0.01% | +33.3% |
| Q2 2021 | $688,000 | +130.1% | 40,846 | +150.2% | 0.01% | +125.0% |
| Q1 2021 | $299,000 | +23.0% | 16,323 | +22.4% | 0.00% | 0.0% |
| Q4 2020 | $243,000 | – | 13,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
| Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
| NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
| Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
| Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
| Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
| Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
| Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
| Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
| Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |